Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome is a rare genetic disorder that affects the development of the brain, kidneys, and urinary tract. It is characterized by severe malformations of the brain, kidneys, and urinary tract, and is usually fatal in the fetus. Symptoms may include hydrocephalus, polycystic kidneys, and abnormal development of the urinary tract. There is no known cure for this disorder.

The symptoms of Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome vary depending on the severity of the condition, but may include:

- Severe growth restriction
- Abnormal facial features
- Abnormal brain development
- Abnormal kidney development
- Abnormal genital development
- Abnormal urinary tract development
- Abnormal heart development
- Abnormal lung development
- Abnormal liver development
- Abnormal gastrointestinal development
- Abnormal skeletal development
- Abnormal skin development
- Abnormal eye development
- Abnormal hearing development
- Abnormal immune system development
- Abnormal blood clotting
- Abnormal blood pressure
- Abnormal blood sugar levels
- Abnormal electrolyte levels
- Abnormal hormone levels
- Abnormal breathing patterns
- Abnormal reflexes
- Ab

Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome is a rare genetic disorder caused by a mutation in the SALL1 gene. This gene is responsible for the development of the kidneys, urinary tract, and reproductive organs. Mutations in this gene can lead to the development of severe malformations in these organs, resulting in the syndrome. Other causes of this syndrome include chromosomal abnormalities, such as trisomy 18, and environmental factors, such as exposure to certain toxins or medications during pregnancy.

Unfortunately, there is no known cure for Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome. Treatment focuses on managing the symptoms and providing supportive care. This may include physical therapy, occupational therapy, speech therapy, and other interventions to help the child reach their fullest potential. In some cases, surgery may be necessary to correct any physical abnormalities. Additionally, medications may be prescribed to help manage any associated medical conditions.

1. Advanced maternal age
2. Family history of genetic disorders
3. Maternal exposure to certain medications or environmental toxins
4. Maternal diabetes
5. Maternal obesity
6. Maternal smoking
7. Maternal alcohol consumption
8. Maternal infection during pregnancy
9. Maternal malnutrition
10. Maternal use of certain recreational drugs

Unfortunately, there is no known cure or medications for Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome. Treatment is supportive and focuses on managing the symptoms of the condition. This may include physical therapy, occupational therapy, speech therapy, and other interventions to help the individual reach their highest level of functioning.